Market Cap 1,000.00
Revenue (ttm) 50.29M
Net Income (ttm) -34.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -67.83%
Debt to Equity Ratio 1.95
Volume 300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 8.88M
Stochastic %K N/A
Beta 3.67
Analysts Strong Buy
Price Target $3.00

Company Profile

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, contin...

Industry: Medical Devices
Sector: Healthcare
Phone: 855 646 7874
Address:
4255 Burton Drive, Santa Clara, United States
NVDAMillionaire
NVDAMillionaire Mar. 28 at 7:32 PM
$UTRS Digging the uterine tech play. Potential game-changer in minimally invasive procedures. Watching closely for next moves. in-depth review of recent trends: https://beyondspx.com/article/minerva-surgical-utrs-a-trailblazer-in-minimally-invasive-uterine-healthcare-solutions
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 8 at 11:44 PM
$UTRS Minerva Surgical, Inc. (NASDAQ:UTRS) – A Detailed Look at the Minimally Invasive Medical Device Company https://beyondspx.com/article/minerva-surgical-inc-nasdaq-utrs-a-detailed-look-at-the-minimally-invasive-medical-device-company
0 · Reply
NVDAMillionaire
NVDAMillionaire Aug. 16 at 8:08 PM
$UTRS Minerva Surgical, Inc. (NASDAQ:UTRS) – A Detailed Look at the Minimally Invasive Medical Device Company http://beyondspx.com/2024/08/05/minerva-surgical-inc-nasdaqutrs-a-detailed-look-at-the-minimally-invasive-medical-device-company/
1 · Reply
NinjaTwits
NinjaTwits Jul. 5 at 3:16 PM
0 · Reply
Alienfrom5thDimension
Alienfrom5thDimension May. 30 at 3:20 AM
$UTRS Does this thing even trade on the pink sheets?
0 · Reply
RAntar
RAntar May. 27 at 10:51 PM
$UTRS For a moment, my shares showed $2.35. Does anyone know anything? Have you received any reports, news, or something?
0 · Reply
B1234real
B1234real May. 13 at 7:46 PM
$UTRS deader than dead. WOW lol
0 · Reply
Ditchg
Ditchg Mar. 28 at 4:23 PM
$UTRS so what does this delisting mean in terms of shares people hold? Can we choose to keep what we own? Also what’s up with the date? That’s already come and gone.
0 · Reply
TickerDD_com
TickerDD_com Feb. 7 at 7:20 PM
From 2/2/2024, looking back across 22 Month-Ends for UTRS, Percentage Change of Average Monthly Price had More Negatives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $UTRS #UTRS #UTRSStock #TickerDD #UTRSPrice https://www.youtube.com/watch?v=hjtIzssOOO8
0 · Reply
Telefon
Telefon Jan. 14 at 3:28 PM
$ELTP Elite Pharmaceuticals Inc is a company that specializes in the development and manufacturing of generic products. The company focuses on controlled-release drug delivery systems and abuse-deterrent technologies and owns multiple generic products which have been licensed to Prasco LLC and TAGI Pharma. ELTP's operating profits are up 73% over the past year, and the share price has tripled since August. The company is in the process of expanding manufacturing and storage capacity to meet the unprecedented demand for Adderall as a result of a nationwide shortage. They announced the first shipment of generic Adderall XR to Prasco in December. Elite could reach at least $200 million in annual revenues in 1-2 years based on drugs already at or being prepared for submission to FDA. $XXII $ONVO $GOVX $UTRS
1 · Reply
Latest News on UTRS
No data available.
NVDAMillionaire
NVDAMillionaire Mar. 28 at 7:32 PM
$UTRS Digging the uterine tech play. Potential game-changer in minimally invasive procedures. Watching closely for next moves. in-depth review of recent trends: https://beyondspx.com/article/minerva-surgical-utrs-a-trailblazer-in-minimally-invasive-uterine-healthcare-solutions
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 8 at 11:44 PM
$UTRS Minerva Surgical, Inc. (NASDAQ:UTRS) – A Detailed Look at the Minimally Invasive Medical Device Company https://beyondspx.com/article/minerva-surgical-inc-nasdaq-utrs-a-detailed-look-at-the-minimally-invasive-medical-device-company
0 · Reply
NVDAMillionaire
NVDAMillionaire Aug. 16 at 8:08 PM
$UTRS Minerva Surgical, Inc. (NASDAQ:UTRS) – A Detailed Look at the Minimally Invasive Medical Device Company http://beyondspx.com/2024/08/05/minerva-surgical-inc-nasdaqutrs-a-detailed-look-at-the-minimally-invasive-medical-device-company/
1 · Reply
NinjaTwits
NinjaTwits Jul. 5 at 3:16 PM
0 · Reply
Alienfrom5thDimension
Alienfrom5thDimension May. 30 at 3:20 AM
$UTRS Does this thing even trade on the pink sheets?
0 · Reply
RAntar
RAntar May. 27 at 10:51 PM
$UTRS For a moment, my shares showed $2.35. Does anyone know anything? Have you received any reports, news, or something?
0 · Reply
B1234real
B1234real May. 13 at 7:46 PM
$UTRS deader than dead. WOW lol
0 · Reply
Ditchg
Ditchg Mar. 28 at 4:23 PM
$UTRS so what does this delisting mean in terms of shares people hold? Can we choose to keep what we own? Also what’s up with the date? That’s already come and gone.
0 · Reply
TickerDD_com
TickerDD_com Feb. 7 at 7:20 PM
From 2/2/2024, looking back across 22 Month-Ends for UTRS, Percentage Change of Average Monthly Price had More Negatives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $UTRS #UTRS #UTRSStock #TickerDD #UTRSPrice https://www.youtube.com/watch?v=hjtIzssOOO8
0 · Reply
Telefon
Telefon Jan. 14 at 3:28 PM
$ELTP Elite Pharmaceuticals Inc is a company that specializes in the development and manufacturing of generic products. The company focuses on controlled-release drug delivery systems and abuse-deterrent technologies and owns multiple generic products which have been licensed to Prasco LLC and TAGI Pharma. ELTP's operating profits are up 73% over the past year, and the share price has tripled since August. The company is in the process of expanding manufacturing and storage capacity to meet the unprecedented demand for Adderall as a result of a nationwide shortage. They announced the first shipment of generic Adderall XR to Prasco in December. Elite could reach at least $200 million in annual revenues in 1-2 years based on drugs already at or being prepared for submission to FDA. $XXII $ONVO $GOVX $UTRS
1 · Reply
bizzarrekrazzy101
bizzarrekrazzy101 Jan. 8 at 4:37 PM
$UTRS 95% shorted👀
0 · Reply
Newguy21
Newguy21 Jan. 3 at 7:40 PM
$UTRS we going up
0 · Reply
More_is_NeverEnough
More_is_NeverEnough Dec. 29 at 7:47 PM
$UTRS whoever sold at today’s lows. You’re an idiot 😂
0 · Reply
The_Hyneman
The_Hyneman Dec. 29 at 6:41 PM
$UTRS unfortunately, no delisting run here
0 · Reply